Evidence map›Paper›PMID 25161789›Full record

ArticleCase reports in oncological medicine2014

Concomitant bifocal urothelial carcinoma and breast tumor: second primary cancer or metastatic spread to the breast?

Clément Dumont, Hélène Gauthier, Jérôme Vérine, Jacqueline Lehmann-Che, Patricia de Cremoux, Damien Pouessel, Stéphane Culine

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncological medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Clément DumontDepartment of Medical Oncology, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Hélène GauthierDepartment of Medical Oncology, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Jérôme VérineDepartment of Pathology, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Jacqueline Lehmann-CheMolecular Oncology Unit, Department of Biochemistry, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Patricia de CremouxMolecular Oncology Unit, Department of Biochemistry, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Damien PouesselDepartment of Medical Oncology, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Stéphane CulineDepartment of Medical Oncology, AP-HP, Saint-Louis Hospital, University Paris Diderot, 75010 Paris, France.
Assistance Publique – Hôpitaux de Paris · FRUniversité Paris Cité · FRDélégation Paris 7 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastases to the mammary gland are an uncommon event in the natural history of most malignant tumors. We report the case of a 60-year-old woman who presented initially with bifocal urothelial carcinoma with a single breast tumor, raising the issue of a primary cancer or a metastatic spread to the breast. The diagnosis of breast metastasis was aided by identity of pathology, immunochemistry, and molecular biology findings between the primary tumor and the breast lesion, among which are the p.K120M mutation, a very rare TP53 mutation, and HER2 overexpression with underlying polysomy of chromosome 17.

Identifiers

PMID25161789
PMCPMC4137750
OpenAlexW1979393772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.